Novozymes A/S
DKK 465.30+DKK 0.10 (+0.02%)
Novozymes A/S’s quoted price sits in the upper half of its reported 52-week range, 3.36% below the high.
CPH · SIG.CO · DKK
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · DKK. Historical prices are not a forecast.
Scandinavian Investment Group A/S’s quoted price sits in the lower half of its reported 52-week range, 11.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Scandinavian Investment Group A/S’s forward annual dividend is DKK 1.10 per share, paid annual. The forward yield is 32.32% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Scandinavian Investment Group A/S’s reporting calendar.
THE COMPANY BEHIND THE TICKER
This Danish investment group manages a diverse portfolio, including real estate properties located within Denmark. Additionally, the company makes strategic investments in publicly traded and private enterprises, alongside various bonds, across the Nordic markets. Scandinavian Investment Group A/S was established in 1908 and operates from its base in Herlev, Denmark.
Latest available per-share figures in DKK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
DKK 465.30+DKK 0.10 (+0.02%)
Novozymes A/S’s quoted price sits in the upper half of its reported 52-week range, 3.36% below the high.
DKK 200.00+DKK 3.60 (+1.83%)
Rockwool A/S’s quoted price sits in the upper half of its reported 52-week range, 14.97% below the high.
DKK 17.13-DKK 0.50 (-2.84%)
Alm. Brand A/S’s quoted price sits in the upper half of its reported 52-week range, 10.5% below the high.
DKK 464.00+DKK 1.00 (+0.22%)
SP Group A/S’s quoted price sits in the upper half of its reported 52-week range, 6.64% below the high.
DKK 96.30-DKK 0.10 (-0.1%)
cBrain A/S’s quoted price sits in the lower half of its reported 52-week range, 39.43% below the high.
DKK 50.40+DKK 0.20 (+0.4%)
North Media A/S’s quoted price sits in the upper half of its reported 52-week range, 4.18% below the high.
DKK 34.00-DKK 0.50 (-1.45%)
Rovsing A/S’s quoted price sits in the lower half of its reported 52-week range, 48.87% below the high.
DKK 7.12-DKK 0.22 (-3.0%)
Skako A/S’s quoted price sits in the lower half of its reported 52-week range, 90.19% below the high.